[Hot Stock] LabGenomics, World's First Real-Time PCR Kit Diagnosing COVID-19 Within 35 Minutes

[Asia Economy Reporter Hyungsoo Park] LabGenomics has been on the rise for the second consecutive day. The news that it is launching the world's first real-time PCR kit capable of diagnosing COVID-19 within one hour appears to have influenced its stock price.

As of 9:35 a.m. on the 25th, LabGenomics is trading at 29,000 KRW, up 14.17% from the previous day.

After soaring to the daily price limit the day before, it has been surging for two consecutive days.

On the 24th, LabGenomics announced that it had obtained both the Korea Disease Control and Prevention Agency's emergency use authorization and the Ministry of Food and Drug Safety's export approval for the 'LabGun COVID-19 Exo FAST RT-PCR Kit,' developed through a performance improvement process.

The diagnostic kit was developed to perform the entire process from specimen preprocessing (RNA extraction) to result output within one hour. While existing real-time PCR kits take about 2 hours and 30 minutes from RNA extraction to result output, LabGenomics shortened this to 35 minutes. Testing times in the 30-minute range have so far only been possible with isothermal PCR, but this has been realized for the first time in the world with real-time PCR.

The company stated, "This will be highly useful in countries with limited testing equipment and severe time constraints for testing," adding, "In a global situation where real-time PCR equipment is scarce, testing capacity can be increased more than fivefold per device, so demand is expected in countries with large testing populations such as India, Brazil, and Indonesia."

This content was produced with the assistance of AI translation services.